GURUFOCUS.COM » STOCK LIST » Industrials » Business Services » Proto Script Pharmaceutical Corp (OTCPK:PSCR) » Definitions » Change In Receivables

Proto Script Pharmaceutical (Proto Script Pharmaceutical) Change In Receivables : $-0.03 Mil (TTM As of Sep. 2017)


View and export this data going back to 2011. Start your Free Trial

What is Proto Script Pharmaceutical Change In Receivables?

Proto Script Pharmaceutical's change in receivables for the quarter that ended in Sep. 2017 was $-0.08 Mil. It means Proto Script Pharmaceutical's Accounts Receivable increased by $0.08 Mil from Jun. 2017 to Sep. 2017 .

Proto Script Pharmaceutical's change in receivables for the fiscal year that ended in May. 2016 was $0.00 Mil. It means Proto Script Pharmaceutical's Accounts Receivable stayed the same from May. 2015 to May. 2016 .

Proto Script Pharmaceutical's Accounts Receivable for the quarter that ended in Sep. 2017 was $0.17 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Proto Script Pharmaceutical's Days Sales Outstanding for the three months ended in Sep. 2017 was 60.11.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Proto Script Pharmaceutical's liquidation value for the three months ended in Sep. 2017 was $-1.55 Mil.


Proto Script Pharmaceutical Change In Receivables Historical Data

The historical data trend for Proto Script Pharmaceutical's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Proto Script Pharmaceutical Change In Receivables Chart

Proto Script Pharmaceutical Annual Data
Trend May12 May13 May14 May15 May16
Change In Receivables
- - - - -

Proto Script Pharmaceutical Quarterly Data
Nov12 Feb13 May13 Aug13 Nov13 Feb14 May14 Aug14 Nov14 Feb15 May15 Aug15 Nov15 Feb16 May16 Sep16 Dec16 Mar17 Jun17 Sep17
Change In Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - 0.04 - -0.08

Proto Script Pharmaceutical Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Sep. 2017 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.03 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Proto Script Pharmaceutical  (OTCPK:PSCR) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Proto Script Pharmaceutical's Days Sales Outstanding for the quarter that ended in Sep. 2017 is calculated as:

Days Sales Outstanding
=Accounts Receivable/Revenue*Days in Period
=0.166/0.252*91
=60.11

2. In Ben Graham's calculation of liquidation value, Proto Script Pharmaceutical's accounts receivable are only considered to be worth 75% of book value:

Proto Script Pharmaceutical's liquidation value for the quarter that ended in Sep. 2017 is calculated as:

Liquidation Value
=Cash, Cash Equivalents, Marketable Securities-Total Liabilities+(0.75 * Accounts Receivable)+(0.5 * Total Inventories)
=0-1.676+0.75 * 0.166+0.5 * 0
=-1.55

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Proto Script Pharmaceutical Change In Receivables Related Terms

Thank you for viewing the detailed overview of Proto Script Pharmaceutical's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.


Proto Script Pharmaceutical (Proto Script Pharmaceutical) Business Description

Traded in Other Exchanges
N/A
Address
9830 6th Street, Suite 103, Rancho Cucamonga, CA, USA, 91730
Proto Script Pharmaceutical Corp is primarily in the business of repair power wheelchairs and scooters, which are classified as durable medical equipment (DME) products and reimbursable by healthcare insurance providers. It has various contracts with state and governmental insurance providers, among others. These contracts provide the company with the right to sell and repair DME and its health care insurance contracts allow it the ability to service patients nationally. The group currently has its presence of repair facilities in Las Vegas, Nevada, Rancho-Cucamonga, and Anaheim, California.

Proto Script Pharmaceutical (Proto Script Pharmaceutical) Headlines

No Headlines